Patent details

EN | LT

LT - (S)-2-amino-4-metil-1-((R)-2-metiloksiran-2-il)-pentan-1-ono sintezė ir jo farmaciniu požiūriu priimtina druska

EN - SYNTHESIS OF (S)-2-AMINO-4-METHYL-1-((R)-2-METHYLOXIRANE-2-YL)-PENTAN-1-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

Legal status

Patent in force

Claims | Licences

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07D 303/36	(2006.01)
		C01G 45/00	(2006.01)

European patent
(11)	Number of the document	3494108
(13)	Kind of document	T
(96)	European patent application number	17751954.3
	Date of filing the European patent application	2017-08-03
(97)	Date of publication of the European application	2019-06-12
(45)	Date of publication and mention of the grant of the patent	2020-10-28
(46)	Date of publication of the claims translation	2021-01-25

PCT application
(86)	Number	PCT/US2017/045274
	Date	2017-08-03

PCT application publication
(87)	Number	WO 2018/027021
	Date	2018-02-08

Inventors
(72)	BEAVER, Matthew, US CUI, Sheng, US SHI, Xianqing, US

Grantee
(73)	Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, US

Attorney or representative
(74)	Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT

Title
(54)	(S)-2-amino-4-metil-1-((R)-2-metiloksiran-2-il)-pentan-1-ono sintezė ir jo farmaciniu požiūriu priimtina druska
	SYNTHESIS OF (S)-2-AMINO-4-METHYL-1-((R)-2-METHYLOXIRANE-2-YL)-PENTAN-1-ONE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-07-23	9	208.00 EUR

Next renewal fee
	2026-08-03